← Evidence map

ArticleCell & bioscience2023

FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB.

Mi-Jeong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37287005